Cohance Lifesciences Ltd
TURNAROUNDMEDIUMHealthcareBSE: 543064NSE: COHANCE
Final Score
73/100
Geometric mean of 5 dimension scores
ClassificationQUANT
POTENTIAL LONG
Overall Rank
#415
Sector Rank
#35
Healthcare
Price-to-Earnings Ratioi
39.1×
▼ vs sector 30.4×
Return on Capital Employedi
14.9%
≈ sector 14%
Return on Equityi
12.7%
≈ sector 12.7%
Piotroski F-Scorei
4/9
Market Capitalizationi
₹11.8K Cr
▲ vs sector ₹1.1K Cr
Dividend Yieldi
0%
≈ sector 0%
Catalysts
- +Company's working capital requirements have reduced from 96.3 days to 74.1 days
Risks
- −Though the company is reporting repeated profits, it is not paying out dividend
- −The company has delivered a poor sales growth of 7.51% over past five years.
- −Dividend payout has been low at 12.4% of profits over last 3 years
- −Debtor days have increased from 54.4 to 86.7 days.